Rosthorn snake gourd

Rosthorn Snake Gourd (Trichosanthes rosthornii Harms): A Comprehensive Reference

1. Identity and Botanical Description

1.1 Scientific Classification and Nomenclature

Rosthorn snake gourd is the common English name applied to Trichosanthes rosthornii Harms, a species in the genus Trichosanthes within the family Cucurbitaceae (the gourd or cucumber family). The genus Trichosanthes consists of tropical and subtropical vines belonging to the cucumber family, Cucurbitaceae. The Trichosanthes genus comprises 90–100 plant species found worldwide, typically thriving on shaded slopes within forest understories and shrub vegetation at elevations ranging from 200 to 1800 m.

The species epithet rosthornii commemorates the German explorer Arthur von Rosthorn. Within the pharmacopeial and ethnobotanical literature, T. rosthornii is almost always discussed in close conjunction with its congener Trichosanthes kirilowii Maxim., as both species supply the same official medicinal materials under Chinese and Korean pharmacopeial standards. It is one of the 50 fundamental herbs used in traditional Chinese medicine, where it shares the name guālóu (Chinese: 栝蔞) with the related T. rosthornii.

The genus name Trichosanthes is of Greek derivation. In the scientific name, Trichosanthes is derived from the Greek words "trichos," meaning hair, and "anthos," meaning flower, reflecting the plant's hairy stems and flowers.

1.2 Pharmacopeial Status and Official Designations

T. rosthornii, together with T. kirilowii, is a dual-origin plant recognized in official pharmacopeial monographs for several distinct herbal drug preparations. The dry ripe fruits of T. kirilowii and T. rosthornii (Fam. Cucurbitaceae) have been registered as Trichosanthis Fructus (TF) in the Chinese Pharmacopoeia since 1977. The radixes (Trichosanthis Radix; "Tianhuafen" in Chinese), seeds (Trichosanthis Semen; "Gualouzi" in Chinese), and pericarps (Trichosanthis Pericarpium; "Gualoupi" in Chinese) of these two plants are also used in clinical practice for different purposes.

Trichosanthis Fructus ("Gualou" in Chinese, "Hanultari" in Korean, and "Zenkaro" in Japanese) is considered an essential medicine to treat thoracic obstruction. T. kirilowii and T. rosthornii are species within the Cucurbitaceae family, widely recognized for their medicinal value in traditional Chinese and Korean medicine.

1.3 Botanical Features and Natural Distribution

T. rosthornii is a perennial climbing vine. T. kirilowii and T. rosthornii have a long history of medicinal use in China starting from the Eastern Han Dynasty, perhaps earlier. Nearly every part of the plant was exploited for medicine or food in ancient times. Like all members of the genus, it bears white flowers with the characteristic lacy, fringed petals that give Trichosanthes its name, and it produces gourd-like fruits that ripen from green to reddish-yellow or orange. Trichosanthes shoots, tendrils, and leaves of some or possibly all species may be eaten as greens.

1.4 Common Forms and Preparations

Multiple distinct plant parts are prepared and used as separate herbal medicines, each with its own pharmacopeial name:

• Trichosanthis Fructus (Gualou / Quangualou): The whole dried ripe fruit, used primarily for thoracic and cardiovascular indications.
• Trichosanthis Pericarpium (Gualoupi): The dried fruit pericarp (peel), emphasized in formulas for respiratory conditions.
• Trichosanthis Semen (Gualouren): The seeds, used for intestinal lubrication and constipation.
• Trichosanthis Radix (Tianhuafen): The dried root tuber, used for heat-clearing and fluid-generating purposes, and the source of the protein trichosanthin.

Trichosanthes Fruit, known as Gua Lou in Chinese, is the dried, mature fruit of Trichosanthes kirilowii or Trichosanthes rosthornii from the Cucurbitaceae family. It is used in three forms — whole fruit (Quan Gua Lou), fruit peel (Gua Lou Pi), and seeds (Gua Lou Ren) — each with specific benefits.

When powdered and made into pills (as traditionally done with Gualou Qumai Wan), trichosanthes is consumed at a dose of 2–3 grams daily. In clinical TCM practice, the fruits are also prepared as decoctions (water-based boiled extracts), and the root protein trichosanthin is administered parenterally (by injection) for specified obstetric and oncological indications.

2. Traditional and Historical Use

2.1 China: Origins in Classical Texts

T. kirilowii and T. rosthornii have a long history of medicinal use in China starting from the Eastern Han Dynasty, perhaps earlier. Nearly every part of the plant was exploited for medicine or food in ancient times. Trichosanthis Radix (TR), another famous Chinese medicine used to treat Xiaoke (similar to diabetes), may have been the first Trichosanthis species used, with the first evidence recorded in the Shen Nong Ben Cao Jing, the earliest treatise on medicine in China.

Trichosanthes Fruit has been documented in ancient Chinese medical texts for centuries. The Shennong Bencao Jing (Shennong's Classic of Materia Medica) lists it as a middle-grade herb, noting it "treats chest and abdominal stagnation, masses, hernias, breast difficulties, and abscesses." The Mingyi Bielu further describes it as effective for "heart pain, cough, thirst, lung dryness, swelling, and dispersing masses."

Trichosanthes fruit is described in the Shennong Bencao Jing as: Gualou is bitter and cold. It mainly treats wasting, thirst, generalized fever, vexatious fullness, and great heat. It supplements vacuity, quiets the center, and mends expiry and damage.

The traditional medical book Qianjin Yifang by Sun Simiao was the first recording of Tian Hua Fen (the root powder) in the 7th century. The Taiping Royal Prescriptions by Wang Huaiyin and the Compendium of Materia Medica by Li Shizhen have also recorded it in prescriptions to deal with abortion, abnormal menstruation, and retained placenta.

Later, Trichosanthis Fructus and Trichosanthis Radix shared the name "Gualou" for a period of time, probably because of language conventions. In Lei Gong Pao Zhi Lun, the differences between the pericarps, seeds, twigs, and radixes were first put forward and were further expounded in Ming Yi Bie Lu. The primary uses of the plant parts include radixes for treating Xiaoke, fruits for thoracic obstruction, and twigs for heatstroke.

In the Bencao Gangmu, Li Shizhen provided a detailed account of Trichosanthes Fruit's appearance, origin, and effects. He noted it grows wild in mountains, spreading like a melon vine with rough, sweet melon-like leaves. The fruit, about the size of a chicken egg, is green when young and reddish-yellow when ripe, with white flesh and red pulp. Its root, called Gua Lou Gen, is also medicinal. He described the distinct effects of the whole fruit, peel, and seeds.

2.2 Classical Formula Context

In the classical TCM formulary Jin Gui Yao Lue (Synopsis of the Golden Chamber), the fruit of Trichosanthes — under the name Gualou, sourced from both T. kirilowii and T. rosthornii — was a principal ingredient in foundational cardiovascular prescriptions. Gualou Xiebai is a basic prescription for the treatment of angina pectoris in the Synopsis of the Golden Chamber. The formula has been summarized in theoretical research and clinical application with the aim of promoting its use in clinical practice. Trichosanthes kirilowii Maxim or Trichosanthes rosthornii Harms is derived from the genus Trichosanthes. It has the functions of clearing heat, removing phlegm, moistening lungs, relieving cough, broadening the breasts, and smoothing intestines.

2.3 Traditional Uses Across Plant Parts

In traditional Chinese medicine it is said to drain heat and generate fluids, clear and drain lung heat, transform phlegm, and moisten lung dryness, and resolve toxicity and expel pus. The root tuber, known as Tianhuafen (literally "heavenly flower powder"), held a distinct therapeutic role: the root tuber has long been used in traditional Chinese medicine (TCM) as an abortifacient called Tian Hua Fen.

Trichosanthis Radix, derived from the roots of Trichosanthes kirilowii Maximowicz and Trichosanthes rosthornii Harms, is used widely in traditional Asian medicine. It has been used for centuries across China, Japan, South Korea, and other Asian countries to treat several ailments, including diabetes, cancer, inflammation, cardiovascular and respiratory conditions. The pharmacopoeias in several countries recognize its ability to clear heat, reduce swelling, expel pus, generate fluids, and regulate menstruation.

According to the theory of Miao medicine, radixes relieve cough and reduce sputum to treat pulmonary tuberculosis, chronic bronchitis, and sore throats.

2.4 Korea and Japan

Other parts of this medicinal plant such as fruits, pericarps, and seeds have different definite curative effects in clinical uses and have been used extensively since ancient times in Asian countries, including China, Korea, and Japan. T. kirilowii and T. rosthornii are important in Korean and Chinese traditional herbal medicine, as their roots and seeds are used as Trichosanthis Radix and Trichosanthis Semen (herbal medicinal names), respectively.

3. Key Constituents and Active Compounds

3.1 Overview of Phytochemical Diversity

The phytochemistry of T. rosthornii has been extensively characterized in combination with T. kirilowii, as both supply the same pharmacopeial drugs. Approximately 162 compounds, including terpenoids, phytosterols, flavonoids, nitrogenous compounds, and lignans, have been isolated and identified from Trichosanthes kirilowii Maxim. and Trichosanthes rosthornii Harms.

Since 1977, chemical compounds in T. kirilowii and T. rosthornii have been isolated from several plant parts, including seeds, pericarps, fruits, twigs, and roots. At present, 46 terpenoids, 29 phytosterols, 22 flavonoids, 28 nitrogenous compounds, 8 lignans, and 29 other compounds have been identified.

3.2 Major Compound Classes

Terpenoids and Cucurbitacins

Terpenoids form the largest single compound class, including the triterpenoid cucurbitacins (a class characteristic of the Cucurbitaceae family). The phytochemical constituents, including proteins (trichosanthin), terpenoids (cucurbitacins), alkaloids, lignans, coumarins, and flavonoids, which contribute to diverse pharmacological effects including antimicrobial, anti-inflammatory, anticancer, antidiabetic, abortifacient, neuroprotective, immunoregulatory, and antiviral activities, are documented for this genus. Fruit-abundant cucurbitacin B inhibits the STAT3 pathway to exert antitumor effects.

Flavonoids

A significant group of 22 flavonoids has been identified from T. kirilowii and T. rosthornii. Flavonoids display dynamic accumulation patterns: kaempferitrin, quercetin, (+)-catechin, apigenin, naringenin, luteolin, and rutin are among those characterized across fruit development stages. By HPLC analysis, ten flavones, three tetracyclic triterpenoids, and one pentacyclic triterpenoid in the extracts of T. kirilowii have been determined.

Phytosterols

Twenty-nine phytosterols have been identified. Early chemical work specifically on the pericarp of T. rosthornii yielded sterol-type compounds: nine compounds were isolated from the pericarp of T. rosthornii and identified on the basis of spectral data to be palmitic acid, lignoceric acid, cerotic acid, montanic acid, melissic acid, L-(−)-alpha-monopalmitin, delta 7-stigmastenol, delta 7-stigmastenone-3, and delta 7-stigmatenol-3-beta-D-glucopyranoside.

Nitrogenous Compounds and Trichosanthin

The most pharmacologically prominent nitrogenous constituent is the protein trichosanthin, concentrated in the root tuber. Trichosanthin (TCS) is a type I ribosome-inactivating protein (RIP), purified from the root tubers of Trichosanthes kirilowii. Trichosanthin, or Tian Hua Fen, is obtained from the root tuber of Trichosanthes kirilowii Maxim belonging to the Cucurbitaceae family. The seeds contain a distinct fatty acid profile: seed lipids comprise approximately 35% of seed weight, with over 60% linoleic acid.

Lignans

Eight lignans have been identified. Research on T. kirilowii specifically identified one new lignan, trichobenzolignan, alongside known lignan compounds including ligballinol, (−)-pinoresinol, and others, some with documented cytotoxic activity.

3.3 Mechanisms of Action

Multiple mechanisms have been proposed for the biological activities of T. rosthornii constituents, based on in vitro and animal research:

• Ribosome inactivation: Trichosanthin functions as a type I ribosome-inactivating protein (RIP). Trichosanthin is toxic at high concentrations as a ribosome-inactivating protein (RIP), which accounts for its property as an abortifacient and as an interrupter of protein synthesis and tumor growth. Toxicity-related mechanisms include functioning as RNA N-glycosidase, direct targeting to DNA or ribosomes, and induction of apoptosis.
• STAT3 pathway inhibition: Cucurbitacin B inhibits the STAT3 pathway to exert antitumor effects.
• Anti-inflammatory signaling: Molecular docking simulations demonstrated high-affinity interactions between characteristic components and pivotal targets including PTGS2, MAPK3, CASP3, and BCL2. In vivo investigations showed treatment markedly attenuated myocardial tissue degeneration and suppressed pro-inflammatory cytokine production (IL-6, TNF-α).
• Antioxidant effects: The formulation reduced circulating levels of cardiac injury indicators (LDH, cTnI) and oxidative stress parameters (ROS, MDA).
• Apoptosis regulation: Regarding apoptosis regulation, Pericarpium Trichosanthis injection reduced Bax, caspase-3, and caspase-9, while elevating Bcl-2, effectively inhibiting myocardial cell apoptosis.
• Calcium antagonism and platelet inhibition: The extracts and compounds isolated from these two plants exhibit pharmacological activities, including protection against myocardial ischaemia, calcium antagonist, endothelial cell protection, anti-hypoxic, and anti-platelet aggregation effects.
• Expectorant effects: The herb has shown an ability to reduce chest congestion by breaking down phlegm and aiding in its removal from the lungs.

4. Scientific Evidence by Area of Use

4.1 Cardiovascular System

This is the most extensively researched area of pharmacological activity for the fruit-derived preparations of T. rosthornii. Numerous studies have shown that the extracts and compounds isolated from these two plants exhibit pharmacological activities, including protection against myocardial ischaemia, calcium antagonist activity, endothelial cell protection, anti-hypoxic, anti-platelet aggregation, expectorant, anti-inflammatory, cytotoxic, and antioxidant properties. Trichosanthis Fructus is an essential traditional Chinese medicine with pharmacological activities that mainly affect the cardiovascular system.

In modern clinical practice, TF plays an important role in treating angina, cardiac failure, myocardial infarction (MI), arrhythmia during acute myocardial infarction (AMI) reperfusion, pulmonary heart disease, and cerebral ischaemic diseases. Modern pharmacological experiments have revealed that the extracts or compounds from TF possess a variety of biological activities, including actions against hypoxia, myocardial ischaemia, arrhythmia, platelet aggregation, and bacteria.

A recent in vivo study investigated the pericarp preparation specifically: in vivo investigations showed that Pericarpium Trichosanthis injection treatment markedly attenuated myocardial tissue degeneration and collagen deposition, normalized electrocardiographic ST-segment deviations, and suppressed pro-inflammatory cytokine production (IL-6, TNF-α). The formulation concurrently reduced circulating levels of cardiac injury indicators (LDH, cTnI) and oxidative stress parameters (ROS, MDA); regarding apoptosis regulation, treatment reduced Bax, caspase-3, and caspase-9, while elevating Bcl-2. These findings highlight PTI's protective effects against myocardial injury through multi-target modulation of inflammation, oxidation, and apoptosis.

The classical multi-herb decoction Gualou-Xiebai-Banxia Decoction (GXBD), which uses Trichosanthis Fructus as a principal component, has been studied clinically: GXBD is a traditional Chinese herbal formula including Gualou (Trichosanthis Fructus), Xiebai (Allii Macrostemonis Bulbus), Banxia (Pinelliae Rhizoma), and yellow wine. It is a classical therapy for chest stuffiness and pain syndrome and is widely used in the clinical treatment of coronary heart disease. It also shows significant therapeutic effects on pulmonary heart disease, hyperlipidemia, and arrhythmia.

Evidence strength assessment: Most cardiovascular research on T. rosthornii-derived preparations combines animal (rodent) models of myocardial ischaemia with network pharmacology and in vitro assays. The cited clinical use of Gualou-Xiebai formulas in coronary heart disease is largely documented from traditional practice and Chinese-language clinical series rather than rigorously controlled, blinded, randomized clinical trials published in international peer-reviewed journals. The evidence base is, therefore, preliminary to moderate for human benefit, and stronger for mechanistic plausibility.

4.2 Respiratory System

Gualou is valued for its ability to moisten the lungs, clear phlegm, and relieve chest tightness, and is widely used in Traditional Chinese Medicine (TCM) for respiratory and chest-related conditions. The Yaoxing Fu text concisely summarizes its effects as "moistening the lungs, clearing phlegm, and relieving chest tightness."

In traditional Chinese medicine, the seeds and roots of T. kirilowii are used for the treatment of inflammation, cough, phlegm, polydipsia, and diabetes; whereas the tuber has been used as an abortifacient for over 1000 years because of its extreme toxicity to trophoblasts.

Evidence strength assessment: Respiratory use is well documented in traditional sources and in vitro expectorant studies, but robust, placebo-controlled human clinical trials specifically isolating T. rosthornii's respiratory benefits are lacking. Evidence remains at the level of traditional documentation and preclinical pharmacology.

4.3 Anticancer / Cytotoxic Activity

The anticancer research on Trichosanthes preparations bearing on T. rosthornii divides into two main lines: (1) the protein trichosanthin (from the root) and (2) cucurbitacins (from the fruit and pericarp).

Trichosanthin (TCS) as a midterm abortifacient medicine has been used clinically in traditional Chinese medicine for centuries. Additionally, TCS manifests pharmacological properties including anti-HIV and anti-tumor activities. TCS has been reported to inhibit cell growth of a diversity of cancers, including cervical cancer, choriocarcinoma, and leukemia/lymphoma.

Regarding the mechanism of anticancer activity: TCS has been found to induce apoptosis, enhance the action of chemokines, and inhibit HIV-1 integrase. Cucurbitacin D dose-dependently reduced colorectal cancer cell viability and induced apoptosis. Network pharmacology pinpointed crucial targets like STAT3, AKT1, CCND1, and CASP3. Molecular docking confirmed strong interactions with these targets. Enrichment analysis highlighted involvement in the PI3K-AKT, JAK-STAT, and ErbB signaling pathways. These findings suggest cucurbitacin D as a potential anti-colorectal cancer agent.

Evidence strength assessment: Anticancer activity for trichosanthin has proceeded through Phase I/II human clinical trials for anti-HIV use, but not as a standalone cancer therapy approved in Western regulatory systems. The cucurbitacin data is currently confined to cell culture and network pharmacology studies, which are preliminary. No large-scale randomized controlled human cancer trials for T. rosthornii extracts are documented in accessible peer-reviewed literature.

4.4 Antidiabetic Activity

Trichosanthis Radix, derived from the roots of Trichosanthes kirilowii Maximowicz and Trichosanthes rosthornii Harms, is used widely in traditional Asian medicine. It has been used for centuries across China, Japan, South Korea, and other Asian countries to treat several ailments, including diabetes, cancer, inflammation, cardiovascular and respiratory conditions. Trichosanthis Radix is a famous Chinese medicine used to treat Xiaoke (similar to diabetes), with the first evidence recorded in the Shen Nong Ben Cao Jing.

Evidence strength assessment: Traditional use for a diabetes-like condition (Xiaoke) is well documented historically. Preclinical (animal model) evidence supports antidiabetic plausibility for the root and fruit preparations, but controlled human clinical evidence specific to T. rosthornii is not robustly established in the accessible international literature.

4.5 Anti-HIV and Antiviral Activity

After trichosanthin was purified and identified, more biological activities were unveiled. A major finding was that TCS inhibited the replication of human immunodeficiency virus (HIV) in both acutely infected T-lymphoblastoid cells and chronically infected macrophages. This generated great enthusiasm leading to Phase I/II clinical trials. It was shown that TCS lowered serum p24 antigen level and increased CD4+ T cells in HIV-infected patients. However, antigenicity and other side effects precluded further investigation of its potential use as a therapeutic agent.

Research further showed antiherpetic activity: it was demonstrated that TCS is active against herpes simplex virus (HSV) and its efficacy is similar to acyclovir on a molar basis. TCS is more toxic than acyclovir and therefore the calculated therapeutic index is smaller.

Evidence strength assessment: Trichosanthin's anti-HIV activity reached human Phase I/II clinical trial level, demonstrating measurable antiviral effects. However, toxicity and immunogenicity limited therapeutic development. This represents a rare instance of a Trichosanthes-derived compound reaching clinical trial evaluation.

4.6 Anti-inflammatory Activity

Numerous studies have shown that the extracts and compounds isolated from these two plants exhibit pharmacological activities, including anti-inflammatory effects. The pharmacological portfolio of the Trichosanthes genus includes antioxidant, hepatoprotective, anti-inflammatory, immunomodulatory, wound-healing, and antipyretic activities.

Evidence strength assessment: Anti-inflammatory effects are supported primarily by in vitro assays and animal experiments. Human clinical evidence for anti-inflammatory applications specific to T. rosthornii extracts is very limited in the English-language scientific literature.

4.7 Abortifacient Activity (Obstetric Use)

This is the most clinically documented pharmacological use of the root-derived protein trichosanthin. Trichosanthin is currently used in China to induce early and mid-term abortion with over 95% success rate and minimal side effects. The protein is highly toxic to trophoblasts and choriocarcinoma-derived cells, and when administered intra-amniotically causes necrosis of syncytiotrophoblastic cells and fragmentation of placental villi. Clumps of disintegrating cells cause blood clotting and circulation impairment leading to large areas of necrosis in the placenta and death of the foetus.

Evidence strength assessment: The abortifacient efficacy of trichosanthin in clinical use in China is well documented, though this application is restricted to controlled medical settings with parenteral administration of the purified protein. It is not relevant to conventional oral dietary supplement use of the fruit or peel.

5. Body Systems and Health Areas of Association

• Cardiovascular system: Trichosanthis Fructus (ripe fruits of T. kirilowii and T. rosthornii) is an essential traditional Chinese medicine to treat thoracic obstruction, angina, cardiac failure, myocardial infarction, pulmonary heart disease, and some cerebral ischaemic diseases.
• Respiratory system: Used traditionally for clearing phlegm, moistening the lungs, and treating coughs and bronchitis. The herb has shown an ability to reduce chest congestion by breaking down phlegm and aiding in its removal from the lungs.
• Endocrine / metabolic system: Root preparations have been used for Xiaoke (analogous to diabetes mellitus), as recorded from the earliest classical Chinese texts.
• Immune system / oncology: T. kirilowii and T. rosthornii are used in traditional herbal medicine for their immunomodulatory, anti-tumor, and anti-HIV properties.
• Reproductive system: The root-derived protein trichosanthin is established as an abortifacient used in Chinese medicine for early and mid-term pregnancy termination.
• Gastrointestinal system: The seeds (Gualouren) are used in TCM for their laxative and intestinal lubricating properties.

6. Dosage Forms and Reported Dosages

Multiple pharmacopeial preparations of T. rosthornii exist, and dosages differ by plant part, preparation form, and indication. The following are dosages as reported in identified sources:

• Powdered pill form: When powdered and made into pills (as traditionally done with Gualou Qumai Wan), trichosanthes is consumed at a dose of 2–3 grams daily.
• Whole fruit (Gualou / Trichosanthis Fructus) decoction: Used in TCM clinical formulas including Gualou Xiebai Baijiu Tang and Gualou Xiebai Banxia Tang; specific dose ranges for these decoctions in individual formulas were recorded in the Jin Gui Yao Lue and are administered under TCM practitioner guidance.
• Trichosanthin (parenteral use): The protein trichosanthin is administered by injection or IV infusion in clinical obstetric and investigational antiviral settings. Trichosanthin is given by injection or IV once or twice to induce abortion, and repeatedly for treatment of cancer or HIV infection; for IV infusion, 10 mg doses have been referenced. This route of administration is strictly a clinical medical procedure and is not applicable to dietary supplement contexts.

Future research is needed to clarify the different uses of the seeds, pericarps, and fruits. Quality control of investigations of the fruits should be improved, and the potential uses of the flesh, leaves, and twigs should be further explored. This limits definitive dosage guidance for isolated supplemental use of T. rosthornii.

7. Safety Considerations and Notable Interactions

7.1 Trichosanthin: Toxicity and Immunogenicity

The most significant safety concern associated with preparations derived from T. rosthornii relates to trichosanthin, the root-tuber protein. This concern is specific to the root (Trichosanthis Radix / Tianhuafen) and does not apply equivalently to the fruit, peel, or seed in standard oral use.

Antigenicity and other side effects of trichosanthin precluded further investigation of its potential use as a therapeutic agent. There have been efforts to reduce the antigenicity of TCS by molecular manipulation and coupling to PEG.

Trichosanthin is traditionally used to induce abortion, but its antigenicity and short plasma half-life have limited repeated clinical administration.

TCS is more toxic than acyclovir, and therefore the calculated therapeutic index is smaller. Toxicity of TCS varies between cell types; for example, choriocarcinoma is much more sensitive to TCS than hepatoma.

Concerns with therapeutic safety of trichosanthin represent serious obstacles in its utility as an anti-HIV therapeutic. Trichosanthin is a protein isolated from Trichosanthes kirilowii which has been reported to have anti-HIV activity. However, toxicity to normal cells has led to concerns over its clinical utility.

7.2 Reproductive Hazard

TCS produces adverse effects on reproduction in the mouse by causing follicular atresia and degeneration of ovulated oocytes. In fertilized animals, TCS elicits death of syncytiotrophoblasts of placental villi, and consequently, the embryo fails to develop. This action has been related to its uptake by placental trophoblast cells. This established abortifacient mechanism makes root-derived preparations, and particularly purified trichosanthin, absolutely contraindicated in pregnancy.

7.3 General Safety Profile of Fruit and Seed Preparations

The fruit (Trichosanthis Fructus), pericarp (Trichosanthis Pericarpium), and seed (Trichosanthis Semen) preparations have a long history of use in East Asian medicine and are generally used orally in decoction or as part of multi-herb formulas. The plant has demonstrated a favourable safety profile even at high doses in studies examining related Trichosanthes species' fruit and vegetable parts. However, no comprehensive toxicological data package meeting modern regulatory standards has been published specifically for T. rosthornii fruit preparations in isolation.

7.4 Species Authentication and Adulteration Risk

A documented safety and quality concern is the difficulty in distinguishing T. rosthornii from related species, some of which may have different phytochemical profiles. The authenticity of Korean herbal medicines, particularly T. kirilowii var. kirilowii, the recognized medicinal variety, was assessed in comparison to T. kirilowii var. japonica, which is often considered an adulterant. Molecular marker analysis revealed clear genetic differences between these species, particularly in simple sequence repeats (SSRs) and tandem repeat regions. To facilitate precise identification, three novel markers (Tri, TRr, and Trtt) were developed. Adulteration with non-pharmacopeial species or misidentification represents a real-world product quality risk.

7.5 Gaps in Safety Evidence

Future research is needed to clarify the different uses of the seeds, pericarps, and fruits. Quality control of investigations of the fruits should be improved, and the potential uses of the flesh, leaves, and twigs should be further explored. There are no identified systematic reviews or large human safety studies specifically examining adverse event profiles for oral T. rosthornii fruit, peel, or seed supplements as sold in Western dietary supplement markets.

8. Evidence Summary and Research Limitations

Trichosanthes rosthornii Harms is a well-characterized medicinal plant within the framework of traditional Chinese, Korean, and Japanese medicine, with pharmacopeial recognition in multiple national pharmacopeias since at least 1977. Its phytochemistry is extensively documented, with 162 compounds identified from T. rosthornii and the closely related T. kirilowii. Pharmacological research in cell culture and animal models has provided plausible mechanistic support for cardiovascular, respiratory, anti-inflammatory, and antidiabetic activities.

However, several major evidence limitations apply:

• The majority of published pharmacological research investigates T. kirilowii and T. rosthornii collectively; data isolated to T. rosthornii alone are far more limited.
• Most mechanistic studies are in vitro or in rodent models; well-designed, randomized, placebo-controlled human clinical trials of standardized T. rosthornii-derived preparations are sparse in the accessible international literature.
• Clinical applications of Gualou-Xiebai formulas for coronary heart disease have been practiced in China, but systematic reviews of these data meeting CONSORT or Cochrane standards are not yet widely available in English-language literature.
• The trichosanthin protein's pharmacology has advanced furthest toward clinical validation (Phase I/II HIV trials), but toxicity and immunogenicity halted further development.

References

• Yu, J. et al. (2018). Trichosanthis Fructus: botany, traditional uses, phytochemistry and pharmacology. Journal of Ethnopharmacology. ScienceDirect.
• Trichosanthis Radix: A comprehensive review on botany, ethnomedicine, phytochemistry, pharmacology, quality control and toxicology (2025). Fitoterapia. ScienceDirect.
• Trichosanthes kirilowii — an overview. ScienceDirect Topics.
• Trichosanthes — an overview. ScienceDirect Topics.
• A Sixty-Year Research and Development of Trichosanthin, a Ribosome-Inactivating Protein. PMC / NIH.
• Anti-tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: a mini review. PMC / NIH.
• Trichosanthin, a potent HIV-1 inhibitor, can cleave supercoiled DNA in vitro. PMC / NIH.
• Pericarpium Trichosanthis Injection Protects Isoproterenol-Induced Acute Myocardial Ischemia via Suppressing Inflammatory Damage and Apoptosis Pathways. PMC / NIH.
• [Chemical constituents of the pericarp of Trichosanthes rosthornii Harms]. PubMed (PMID: 1872972).
• Trichosanthes kirilowii. Wikipedia.
• Trichosanthes (genus). Wikipedia.
• Zheng, Y.-T. et al. (2001). Enhancement of the anti-herpetic effect of trichosanthin by acyclovir and interferon. FEBS Letters. Wiley Online Library.
• Structure-function relationship of trichosanthin. Life Sciences. ScienceDirect.
• Protective effects of Trichosanthes on the cardiovascular system. International Journal of Clinical and Experimental Medicine.
• Gualou Xiebai: Basic Prescription for Angina Pectoris — Summary of Clinical Application (2021). Proceedings in Adaptation and Rehabilitation.
• Integrated multiomics profiling elucidates the spatiotemporal metabolic dynamics and regulatory networks of the bioactive components of Trichosanthes kirilowii (2026). Frontiers in Plant Science.
• Trichosanthis Fructus: botany, traditional uses, phytochemistry and pharmacology. ResearchGate.
• Exploring Trichosanthes dioica: A Comprehensive Study of Its Ethnomedical Uses, Phytochemistry, Pharmacology and Toxicity (2025). Chemistry & Biodiversity. Wiley Online Library.
• Dharmananda, S. Trichosanthes. Institute for Traditional Medicine (ITM Online).
• Trichosanthes Fruit Gua Lou: A Traditional Herb for Clearing Phlegm and Relieving Chest Pain. HJ Medical Group.